These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14964637)

  • 21. Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer.
    Sardana K; Garg VK; Manchanda V; Rajpal M
    Br J Dermatol; 2006 Mar; 154(3):573-5. PubMed ID: 16445808
    [No Abstract]   [Full Text] [Related]  

  • 22. Ciclopirox (Penlac) nail lacquer for onychomycosis.
    Med Lett Drugs Ther; 2000 Jun; 42(1080):51-2. PubMed ID: 10859733
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
    Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
    Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).
    Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):suppl 1 p.. PubMed ID: 16518906
    [No Abstract]   [Full Text] [Related]  

  • 25. A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans.
    Gallup E; Plott T;
    J Drugs Dermatol; 2005; 4(1):29-34. PubMed ID: 15696982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of user-friendliness and treatment cost of Loceryl® vs. Ciclopoli®--a patient's perspective.
    Schaller M; Braunsdorf C; Mailänder-Sanchez D; Jäckel A; Müller J; Borelli C
    Mycoses; 2015 Oct; 58(10):632-6. PubMed ID: 26393437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses.
    Lassus A; Nolting KS; Savopoulos C
    Clin Ther; 1988; 10(5):594-9. PubMed ID: 2856602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.
    Gupta AK; Nicol KA
    Int J Dermatol; 2006 Jan; 45(1):66-9. PubMed ID: 16426382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.
    Baran R; Tosti A; Hartmane I; Altmeyer P; Hercogova J; Koudelkova V; Ruzicka T; Combemale P; Mikazans I
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):773-81. PubMed ID: 19453778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study.
    Gupta AK;
    J Drugs Dermatol; 2005; 4(4):481-5. PubMed ID: 16004022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
    Lee JH; Lee HS; Eun HC; Cho KH
    J Dermatolog Treat; 2003 Dec; 14(4):212-5. PubMed ID: 14660265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
    Tosti A; Piraccini BM; Ghetti E; Colombo MD
    J Am Acad Dermatol; 2002 Jul; 47(1):73-6. PubMed ID: 12077585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic paronychia--putting a finger on the evidence.
    Montgomery BD
    Aust Fam Physician; 2006 Oct; 35(10):811, 813. PubMed ID: 17019458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis.
    Clin Ther; 1985; 8(1):41-8. PubMed ID: 2870809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of 40% urea cream in the treatment of moccasin tinea pedis.
    Elewski BE; Haley HR; Robbins CM
    Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How to improve efficacy of onychomycosis treatment?].
    Nowicki R
    Wiad Parazytol; 2001; 47(4):823-32. PubMed ID: 16886434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.